MedPath

Acupuncture for Blood Pressure Fluctuation During Total Laparoscopic Hysterectomy

Not Applicable
Recruiting
Conditions
Neoplasms
Registration Number
KCT0009149
Lead Sponsor
CHA University Ilsan Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria

between age of 19 and 69,
American Society of Anesthesiologists (ASA) class I or II,
required surgical removal of uterus by a gynecology specialist,
scheduled to have total laparoscopic hysterectomy in advance.
agree to participate in clinical trials and providing signed informed consent

Exclusion Criteria

expected survival within 3 months,
emergency operation which was not scheduled in advance,
hypertension or hypotension that can significantly interfere with the study result,
diagnosis of arrhythmia, such as atrial fibrillation, frequent ventricular or supraventricular premature beats,
diagnosis of heart failure or valvular disease,
anemia of hemoglobin < 12 g/dL,
incapable of surgery due to hemodynamic or medical reasons other than stated above,
incapable of receiving acupuncture treatment on determined location,
current use of gonadotropin-releasing hormone receptor agonists,
current use of drugs that may interfere with the result, including steroids, immunosuppressants, and psychiatric disorders,
significant comorbidities that may interfere with the interpretation of intervention efficacy or results, such as stroke, myocardial infarction, kidney disease, dementia, or epilepsy,
pregnant, planning to be pregnant within study period, or breastfeeding,
previous participation in any other clinical trial within 1 month of participation, planning to participate another clinical trial within 6 months after enrollment date, or planning to participate another clinical trial on follow-up period,
fail to write the informed consent form voluntarily,
being deemed to be unsuitable for participation.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
changes in mean blood pressure
Secondary Outcome Measures
NameTimeMethod
blood pressures according to predetermined timepoints;incidence of hypotension;incidence of hypertension;incidence of tachycardia according to predetermined timepoints;incidence of bradycardia according to predetermined timepoints;total use of remifentanil;numeric rating scale for pain;Spielberger's State-Trait Anxiety Inventory (STAI);EuroQoL-5 Dimensions - 5 Levels (EQ-5D-5L)
© Copyright 2025. All Rights Reserved by MedPath